Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Heterozygous ZEB1 (TCF8) variants have been reported in a small number of late-onset Fuchs' endothelial corneal dystrophy (FECD) patients, including a single case with a triple corneal dystrophy phenotype (keratoconus, EBMCD, FECD) bearing a novel exon 7 frameshift (ZEB1) identified in one proband (PMID:25408666) and a recurring missense c.2522A>C (p.Gln841Pro) variant segregating in a single multigenerational FECD pedigree (PMID:20036349). Large cohort screens in Chinese (74 probands; 1 variant) (PMID:18172091), African American (47 probands; benign p.Pro559Ser) (PMID:24348007), and Indian (82 probands; novel nonsense p.Leu947Ter and two missense in 2 cases) (PMID:26622166; 57 cases; 1 recurrent p.Gln841Pro) (PMID:29799290) have identified ZEB1 variation only in 1–2 individuals per study without replication or clear segregation.
Functional studies of ZEB1 missense mutations in corneal endothelial cells demonstrate normal protein abundance and nuclear localization for all tested missense alleles, whereas only truncating PPCD3-associated mutants show impaired stability or mis-localization (PMID:25190660). A recent systematic review of FECD genes concluded no ZEB1 variants meet pathogenic criteria and found no endothelial expression evidence supporting ZEB1 in FECD (PMID:37441688).
Gene–Disease AssociationLimitedFew probands (single case and one pedigree) with ZEB1 variants, lack of robust segregation and inconsistent pathogenicity Genetic EvidenceLimitedHeterozygous ZEB1 variants found in <5 unrelated FECD cases without replication or clear familial segregation Functional EvidenceLimitedMissense ZEB1 proteins show normal abundance and localization in endothelial cell assays; no ZEB1 variants classified as pathogenic in systematic review |